Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesPaclitaxel chemotherapy for the treatment of gastric cancer
Gastric Cancer, 07/02/09
Sakamoto J et al. - With regard to the schedule of paclitaxel administration, weekly injection seemed to show less toxicity and better results than administration every 3 weeks. Adjuvant therapies, chemoradiation therapies, and paclitaxel treatment for gastric ascites were also investigated and are discussed.
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical management of colorectal liver metastases
Community Oncology , 10/09/09
Treatment of Barretts esophagus with high-grade dysplasia and intramucosal adenocarcinoma
Expert Review of Gastroenterology & Hepatology, 10/13/09
Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
The Lancet - Early Online Publication, 10/19/09
Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Sponsor
Article Search
Sponsor